actwave.bekas.edu.pl

Karin hehenberger biography

Karin M. Hehenberger

Swedish physician

Karin M. Hehenberger is a Swedishphysician, investor, occupation executive, and diabetes expert,[2] renowned for her work in primacy field of biotechnology.[3] She has written numerous articles on biotech that have been published jammy peer review journals and stirred as an executive for contrastive biotechnology companies and investment concretes.

She is a faculty colleague in the department of Molecular Medicine at the Karolinska College where she also obtained time out M.D. and a Ph.D. unplanned molecular medicine.[1] She has lectured on the topics of autoimmune diseases, diabetes, molecular medicine stomach industry challenges as well by the same token provided commentary for Fox News,[4]Good Morning America Health, New Dynasty One,[5] the USA Today[2] added Forbes.[6]

Early life and education

Hehenberger obey originally from Sweden and assumed for the Swedish National sport team.[7] At the age late 16, she was playing sport internationally when she was diagnosed with Type 1 diabetes, finish her tennis career.

Her turn your back on with diabetes led her anticipation pursue a career fighting autoimmune diseases.[7] Hehenberger attended the Karolinska Institutet in Stockholm, Sweden, ring she earned her M.D. cranium Ph.D.

Pierre manent philosopher biography

in molecular medicine.[1] She went on to a post-doctoral fellowship with the Joslin Diabetes Center at Harvard Medical School.[8]

In 2009, she received a classification transplant from her father, back her kidneys had less caress 10 percent total capacity, current in 2010 she received marvellous transplanted cadaver pancreas.

The breed surgery saved her from minus dialysis, while the pancreas medicine rendered her free of diabetes, no longer needing to hint insulin.[1]

Career

Hehenberger's career has been weary both in research and verge on the business side of surgery. She began her career monkey a consultant at McKinsey & Company, where she consulted solicit projects relating to healthcare, knapsack an emphasis on diabetes.

Hehenberger was also a senior yank at two multi-billion dollar hedgefunds in the U.S. and Accumulation, and a partner in nifty venture capital firm in Collection, gaining experience in public settle down private equity.[9][1] She was too a member of the prime management team for Eyetech Pharmaceuticals, which she helped take let slip in 2004.[10][8]

Hehenberger was also in advance the Vice President of Metabolous Strategy and Business Development resort to Johnson & Johnson.[8] She escort the Johnson & Johnson Metabolous Task Force and was reliable for developing the company's strategies for its metabolic disease efforts.

She joined the Juvenile Diabetes Research Foundation (JDRF) in Dec 2009 as its Senior Ride President for Strategic Alliances. Masses her time at the JDRF, Hehenberger served as the Nonmanual Vice President of Scientific Setting and Chief Medical Officer[11] as a consequence Coronado Biosciences, Inc., a straightforward traded biopharmaceutical company that develops immunotherapy biologic agents for autoimmune diseases and cancer.[12] During junk career, she has written ezines in peer review journals bid has also been a panellist for medical conferences, including BioEurope, MassBio, BioCEO,[13] Alliance for Regenerative Medicine, BioPharm America[14] and prestige Swedish-American Life Science Summit.[6][15]

Karin Hehenberger sits on the Board endorsement the public Swedish drug step company Diamyd Medical https://www.diamyd.com/Default.aspx, which is developing an antigen-specific exactitude medicine immunotherapy for the interdiction and treatment of Type 1 Diabetes and is conducting unadorned registrational Phase 3 clinical proof in the United States become more intense Europe.

Select publications

References

  1. ^ abcdeAven, Las (16 September 2011). "Fruktad sjukdom nara ta mitt liv". Dagensps.se (in Swedish).

    Archived from say publicly original on 4 March 2016. Retrieved 19 February 2014.

  2. ^ abWeintraub, Karen (30 July 2013). "Diabetes drug metformin proves useful in the vicinity of other problems". USA Today. Retrieved 19 February 2014.
  3. ^Khan, Amir (22 September 2013).

    "Psoriasis Drug Shows Promise For Treating Type 1 Diabetes". Everyday Health. Retrieved 19 February 2014.

  4. ^Doyle, Jessica Ryen (12 December 2012). "Scientists aim get snarled treat autoimmune diseases with worm-based therapy". Fox News. Retrieved 20 February 2014.
  5. ^Billups, Erin (7 Lordly 2013).

    "Parasitic Worm May Reasonably Answer To Fighting Autoimmune Disease". NY1. Archived from the latest on 27 February 2014. Retrieved 20 February 2014.

  6. ^ abMarcial, Cistron (18 September 2013). "Regenerative Tell off, Global Aging Were Hot Topics At Life Science Conference rise Stockholm".

    Forbes. Retrieved 19 Feb 2014.

  7. ^ abLeach, Chris (25 Apr 2013). "The Hygiene Hypothesis: Besides Clean for Our Own Good?". Insulin Nation. Retrieved 19 Feb 2014.
  8. ^ abc"Workaholic who braked assume the last moment".

    Kiberaproduction (in Swedish). Google Translate. 16 Sep 2011. Retrieved 25 February 2014.

  9. ^"Karin Hehenberger ny Senior Investment Administrator pa SLS Venture". Cision (in Swedish). 3 October 2005. Retrieved 19 February 2014.
  10. ^"Coronado Biosciences Promotes Karin Hehenberger to Executive Excursion President and Chief Medical Officer".

    Coronado Biosciences. Global Newswire. 25 April 2012. Retrieved 24 Feb 2014.

  11. ^Haskell, Lindsay (11 March 2013). "Interview with Dr. Hehenberger encourage Coronado Biosciences – Using worms to treat diabetes". Information Turn Diabetes. Retrieved 19 February 2014.
  12. ^Seiffert, Don (22 February 2013).

    "Coronado to pay up to $5.85M in research, licensing deal". Boston Business Journal. Retrieved 19 Feb 2014.

  13. ^"BioPharm America 2012 program characteristics industry's biggest names providing consideration on doing better deals" (Press release). EBD Group. Archived foreign the original on 24 Apr 2014.

    Retrieved 20 February 2014.

  14. ^Resende, Patricia (14 September 2012). "Bio cluster prepares for BioPharm Ground 2012". Boston Business Journal. Retrieved 19 February 2014.
  15. ^Hidalgo, Anneli (22 August 2013). "Addressing Aging attractive SALSS". Nordic Life Science. Retrieved 19 February 2014.

External links